Position in NRIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,167,902
+$886,888 QoQ
Shares Held
377,902
-29.3% QoQ
Ownership
0.364%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#45
of 210 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. NRIX ranks #60 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in NRIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,167,902 | 377,902 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,281,014 | 534,259 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $10,134,893 | 534,259 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $2,424,428 | 262,384 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,988,553 | 262,384 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,996,500 | 588,931 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,956,353 | 634,626 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $23,862,218 | 1,061,959 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $24,297,813 | 1,164,246 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $13,114,017 | 892,110 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $9,474,895 | 918,110 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,609,343 | 968,110 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,188,021 | 1,019,822 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,992,781 | 900,088 | Shares | Other | 2023-05-12 | |
| 2022-12-31 | $9,339,313 | 850,575 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,757,241 | 825,575 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $10,634,881 | 839,375 | Shares | Other | 2022-08-03 | |
| 2022-03-31 | $10,719,134 | 765,106 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $22,989,281 | 794,103 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $16,627,679 | 554,996 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $13,458,748 | 507,303 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $404 | 13 | Shares | Other | 2021-04-29 | |
| No filing history on record for this holder in this stock. | ||||||